| Programme zur Bekämpfung von Krankheiten in Entwicklungsländern [Program to fight against diseases in developing countries] |
| Author(s): Schöffski O1, Fricke F-U2, Gabriel SC3 |
| Affiliations(s): 1 University Erlangen-Nuremberg, Germany 2 IMS Health, Nuremberg, Germany 3 Novartis Pharma AG, Basel, Switzerland |
| Publication(s): Schöffski O, Fricke F-U, Guminski W (ed.). Pharmabetriebslehre, Berlin-Heidelberg, Springer, 2008, 507-524 |
| Document Type(s): Book chapter |
| Countries: |
C:
Y: |
Health policy
2008 |
|
L:
A: |
German
|
|
 |
| |
| |
| Lungenkarzinom in Deutschland - eine kostensparende Option |
| Author(s): Schöffski O1, Fricke FU2, Gabriel SC
|
| Affiliations(s): 1 University Erlangen-Nuremberg, Germany 2 IMS Health, Nuremberg, Germany |
| Publication(s): Schöffski O, Fricke F-U, Guminski W (ed.). Pharmabetriebslehre, Berlin-Heidelberg, Springer, 2008, 507-524 |
| Document Type(s): Book chapter |
| Countries: Germany |
C:
Y: |
Health policy
2008 |
|
L:
A: |
German
|
|
|
| |
| |
| Kosten-Nutzen-Bewertungen von Arzneimitteln werden entscheidungsrelevant [Cost-benefit-assessments become relevant for decision-making]. |
| Author(s): Fricke FU1, Schröder-Bernhardi D2 |
| Affiliations(s): 1 IMS Health, Nuremberg, Germany 2 IMS Health, Frankfurt, Germany |
| Publication(s): Pharm. Ind., 69(2):160-164 |
| Document Type(s): Article |
| Countries: Germany |
C:
Y: |
Health policy
2007 |
|
L:
A: |
German
Cost benefit |
|
|
| |
| |
| Impacto en el mercado de las políticas regionales de racionalización de la prescripción farmacéutica en Andalucía [Market impact of regional racionalization policies on pharmaceutical prescription in Andalucia] |
| Author(s): Badia X1, Lara N1, Vieta A1 |
| Affiliations(s):
1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
|
| Publication(s): XXVII Jornadas de Economía de la Salud (AES). 2007June 6-8, La Coruña, Spain |
| Document Type(s): Oral presentation |
| Countries: Spain |
C:
Y: |
Health policy
2007 |
|
L:
A: |
Spanish
Market impact |
|
|
| |
| |
| Facilitating informed, health literate patients as partners in health: Development of a Direct To Patient Information Model |
| Author(s): Vieta A |
| Affiliations(s): Health Economics and Outcomes Research, Barcelona, Spain |
| Publication(s): 3rd World Ageing & Generations Congress 2007, September 6-8, St Gallen, Switzerland |
| Document Type(s): Oral presentation |
| Countries: |
C:
Y: |
Health policy
2007 |
|
L:
A: |
English
|
|
|
| |
| |
| Recent policy initiatives in the Australian national reimbursement system that have reduced cost dramatically |
| Author(s): Peter Davey. |
| Affiliations(s): |
Publication(s): ISPOR 11th Annual International Meeting
ISPOR 11th International Meeting, 20-24 May 2006 Philadelphia, Pennsylvania, USA. Podium presentation. |
| Document Type(s): Oral presentation |
| Countries: Australia |
C:
Y: |
Health economics, Health policy
2006 |
|
L:
A: |
English
Pricing & Reimbursement |
|
|
| |
| |
| Strategic management. Pharmaceutical generics—a changing playing field |
| Author(s): Davey P |
| Affiliations(s): |
| Publication(s): 4th Annual Pharma Marketing & Sales Congress |
| Document Type(s): Poster |
| Countries: |
C:
Y: |
Health policy
2006 |
|
L:
A: |
English
Budget impact |
|
|
| |
| |
 9 of 9
|
